BLB(SZ:002286) Xin Lang Cai Jing·2025-10-21 02:25Group 1 - The stock of Baolingbao fell by 5.02% on October 21, closing at 9.28 CNY per share, with a trading volume of 77.45 million CNY and a turnover rate of 2.23%, resulting in a total market capitalization of 3.532 billion CNY [1] - Baolingbao Biotech Co., Ltd. is located in Dezhou, Shandong Province, and was established on October 16, 1997, with its listing date on August 28, 2009. The company's main business involves the research, production, and sales of functional sugars [1] - The revenue composition of Baolingbao includes: starch sugars and others 29.89%, sugar-reduced sweeteners 26.55%, feed and by-products 22.40%, probiotics 13.48%, dietary fiber 7.39%, and others (supplements) 0.29% [1] Group 2 - From the perspective of the top ten holdings of funds, one fund under Western Li De has a significant position in Baolingbao. The Western Li De New Fortune Mixed A Fund (673120) held 14,400 shares in the second quarter, accounting for 4.17% of the fund's net value, ranking as the seventh largest holding [2] - The Western Li De New Fortune Mixed A Fund (673120) was established on June 16, 2017, with a latest scale of 1.8184 million. Year-to-date, it has lost 5.36%, ranking 8106 out of 8162 in its category; over the past year, it has lost 7.13%, ranking 7959 out of 8024; since inception, it has achieved a return of 27.84% [2] Group 3 - The fund manager of Western Li De New Fortune Mixed A (673120) is Zhang Changping, who has been in the position for 4 years and 352 days. The total asset scale of the fund is 1.568 billion CNY, with the best fund return during his tenure being 111.93% and the worst being 0.88% [3]